Vitamin D supplementation is effective for olanzapine-induced dyslipidemia

Vitamin D supplementation is effective for olanzapine-induced dyslipidemia

Olanzapine is an atypical antipsychotic drug that is clinically applied in patients with schizophrenia. It increases the risk of dyslipidemia, a disturbance of lipid metabolic homeostasis, usually characterized by increased low-density lipoprotein (LDL) cholesterol and triglycerides, and accompanied...

Full description

Bibliographic Details
Main Authors: Zijian Zhou, Takuya Nagashima, Chihiro Toda, Mone Kobayashi, Takahide Suzuki, Kazuki Nagayasu, Hisashi Shirakawa, Satoshi Asai, Shuji Kaneko
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pharmacology
Subjects:
olanzapine
vitamin D
C2C12 cells
dyslipidemia
clinical big data
low-density lipoprotein
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1135516/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1135516/full

Similar Items